Clinical Trial Update: LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

View source ↗

Summary

This is a clinical trial update for a circulating tumor DNA liquid biopsy study in sarcoma patients (NCT06958107). The trial is currently recruiting at Wake For…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Sarcoma | Status: RECRUITING